Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Short term Debt: 2011

  • EyePoint Pharmaceuticals' Short term Debt was N/A to $128,000 in Q3 2011 from the same period last year, while for Sep 2011 it was $128,000, marking a year-over-year change of. This contributed to the annual value of $170,000 for FY2011, which is N/A change from last year.
  • As of Q3 2011, EyePoint Pharmaceuticals' Short term Debt stood at $128,000, which was down 24.71% from $170,000 recorded in Q2 2011.
  • In the past 5 years, EyePoint Pharmaceuticals' Short term Debt registered a high of $170,000 during Q2 2011, and its lowest value of $128,000 during Q3 2011.
  • Over the past 1 years, EyePoint Pharmaceuticals' median Short term Debt value was $149,000 (recorded in 2011), while the average stood at $149,000.